News
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...
Robbie Williams made headlines last month after revealing that he’d been diagnosed with scurvy, following rapid weight loss ...
Omada Health is launching new AI tools for nutrition care after filing its S-1 to go public.
In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
Ozempic and Wegovy, medications that have become increasingly popular this year due to their weight loss effects, were both tested on a monkey species listed as endangered, according to a National ...
Many play into fads with scant evidence to back up enthusiasts’ claims, medical experts say. Some influencers encourage their ...
Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results